atra stock quote - Yahoo Search Results

Ads
related to: atra stock quote
Invesco QQQ ETF - Explore Top Companies in QQQ

www.invesco.com
invesco.com has been visited by 1M+ users in the past month
Access the Nasdaq's Largest 100 non-financial companies in a Single Investment. Invest in some of today’s most innovative companies, all in one exchange-traded fund (ETF)
10 Best Small Cap Stocks Today - Top Dividend Stocks Under $20

libertythroughwealthnews.com
The Top 10 High-Yielding Dividend Small Cap Stocks for Income Seekers and Retirees. Free Investment Report: Our analysts give 10 dividend stocks under $20 a "buy" rating.

Search results

- Atara Biotherapeutics (NASDAQ:ATRA) shareholders are up 17% this past week, but still in the red...
  Simply Wall St. via Yahoo Finance· 2 years ago
  This week we saw the Atara Biotherapeutics, Inc. (NASDAQ:ATRA) share price climb by 17%. But only...
- Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
  Zacks via Yahoo Finance· 12 hours ago
  Biogen BIIB entered into a definitive agreement to acquire private biotech, HI-Bio, for a $1.15...
- Atara (ATRA) Up 11% on Regulatory Update From Blood Cancer Study
  Zacks via Yahoo Finance· 8 months ago
  Atara (ATRA) rises 11% on an update regarding the regulatory pathway for the company's lead product...
- The past five years for Atara Biotherapeutics (NASDAQ:ATRA) investors has not been profitable
  Simply Wall St. via Yahoo Finance· 1 year ago
  Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shareholders should be happy to see the share price up 19%...
- Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why
  Zacks via Yahoo Finance· 6 months ago
  Atara Biotherapeutics ATRA is a biotech company focused on developing off-the-shelf cell therapies...
- GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
  Zacks via Yahoo Finance· 1 day ago
  GSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
- Acadia's (ACAD) Q2 Earnings & Revenues Surpass Estimates
  Zacks via Yahoo Finance· 2 years ago
  Acadia Pharmaceuticals Inc. ACAD reported a second-quarter 2022 loss of 21 cents per share, narrower...
- Billionaire Seth Klarman’s Biotech Stock Picks
  Insider Monkey via Yahoo Finance· 6 months ago
  In this article, we discuss billionaire Seth Klarman’s biotech stock picks. To skip the detailed analysis of the biotech industry, Seth Klarman’s...
- Horizon (HZNP) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
  Zacks via Yahoo Finance· 2 years ago
  Horizon's (HZNP) earnings and revenues lag estimates in the second quarter of 2022. The company...
- 10 Most Promising Penny Stocks According to Analysts
  Insider Monkey via Yahoo Finance· 9 months ago
  In this article, we will take a look at the 10 most promising penny stocks according to analysts. To see more such companies, go directly to 5 Most...